Semaglutide
STEP UP
Novo Nordisk · Phase 3 · Completed · Enrollment 1407
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Semaglutide 7.2 mg | 88.7% | n/r | n/r | n/r |
| Semaglutide 2.4 mg | n/r | n/r | n/r | n/r |
| Placebo | 38.3% | n/r | n/r | n/r |
Not shown
- Semaglutide 2.4 mg: endpoint not reported